Clinical assessment of risk factors for infection in inflammatory bowel disease patients

Safety of Biologic Therapy in Older Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

(2019) Nienke Z. Borren et al.   Clinical Gastroenterology and Hepatology

Relevant infections in inflammatory bowel disease, their relationship with immunosuppressive therapy and their effects on disease mortality

(2019) Yamile Zabana et al.   Journal of Crohns & Colitis

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

(2018) Julien Kirchgesner et al.   GASTROENTEROLOGY

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

(2017) Fernando Magro et al.   Journal of Crohns & Colitis

Crohn’s Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab

(2016) Mark T Osterman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease

(2016) Marius Vögelin et al.   PLoS One

Visceral Adipose Tissue in Patients with Crohnʼs Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome

(2015) Carsten Büning et al.   INFLAMMATORY BOWEL DISEASES

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

Oral Corticosteroids and the Risk of Serious Infections in Patients With Elderly-Onset Inflammatory Bowel Diseases

(2014) Paul Brassard et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

(2014) Roberto Lorenzetti et al.   ANNALS OF MEDICINE

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2014) J.F. Rahier et al.   Journal of Crohns & Colitis

Serum adipokines in inflammatory bowel disease

(2014) Marek Waluga   WORLD JOURNAL OF GASTROENTEROLOGY

Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013)

(2013) José Luis Cabriada et al.   Gastroenterologia y Hepatologia

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases

(2012) Ashwin N. Ananthakrishnan et al.   Journal of Crohns & Colitis

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

(2012) Makoto Naganuma et al.   JOURNAL OF GASTROENTEROLOGY

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

(2010) Mario Cottone et al.   Clinical Gastroenterology and Hepatology

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT